Belmont, CA, United States of America

Paula J Shadle


Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 314(Granted Patents)


Location History:

  • Richmond, CA (US) (1989)
  • Belmont, CA (US) (1992)

Company Filing History:


Years Active: 1989-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Paula J. Shadle: Innovator in Bioconjugate Technologies**

Introduction

Paula J. Shadle is a notable inventor based in Belmont, California. With a focus on bioconjugate methodologies, she has made significant contributions to the field, securing two patents that showcase her innovative prowess. Her work primarily revolves around enhancing the efficacy of biologically active proteins.

Latest Patents

One of Paula's latest patents, titled "Conjugation of polymer to colony stimulating factor-1," demonstrates her expertise in the manipulation of protein structures. This invention involves the selective conjugation of a biologically active CSF-1 protein to various water-soluble polymers such as polyethylene glycol or polypropylene glycol. The resulting conjugated CSF-1 maintains biological activity while exhibiting an increased circulating half-life in mammals compared to its unconjugated form. This innovative approach has promising applications in stimulating immune responses and enhancing cellular proliferation.

Career Highlights

Paula J. Shadle is currently associated with Cetus Corporation, where she continues to drive research in bioconjugate technologies. Her innovative spirit and scientific acumen have positioned her as a leader in her field, contributing to the development of products that could potentially transform therapeutic practices.

Collaborations

Throughout her career, Paula has collaborated with esteemed colleagues such as Kirston E. Koths and Margaret Moreland. These partnerships have allowed her to merge different expertise areas, ultimately enriching her research and broadening the impact of her inventions.

Conclusion

Paula J. Shadle stands out as an impactful inventor in the realm of bioconjugate technologies. With her innovative patents and collaborations within Cetus Corporation, she continues to pave the way for advancements in immunotherapy and protein engineering. Her work not only highlights her individual talents but also the collective effort necessary to drive innovation in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…